Nevanimibe hydrochloride ( PD-132301 hydrochloride ) is a selective acyl-CoA : cholesterol O-acyltransferase 1 inhibitor with an EC50 of 9 nM. It inhibits ACAT2 with an EC50 of 368 nM. It induces apoptosis and has the potential to resist adrenocortical carcinoma. In vitro activityIn H295R human adrenocortical carcinoma cells, Nevanimibe hydrochloride(ATR-101 hydrochloride) decreases the formation of cholesteryl esters and increases FC levels, demonstrating potent inhibition of ACAT1 activity. Caspase-3/7 levels and terminal deoxynucleotidyl transferase 2'-deoxyuridine 5'-triphosphate nick end labeled-positive cells are increased by ATR-101 treatment, indicating activation of apoptosis.
Specifictaions: Moligand™, ≥98%
MDL Number: C27H40ClN3O
Molecular Formula: 458.08
PubChem CID: 131678
Isomeric SMILES: CC(C)C1=C(C(=CC=C1)C(C)C)NC(=O)NCC2(CCCC2)C3=CC=C(C=C3)N(C)C.Cl
- UPC:
- 51131509
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- N650144-25mg
- CAS:
- 133825-81-7
- Product Size:
- 25mg
akash.verma@cenmed.com
(732) 447-1115





